Published in Arthritis Rheum on February 01, 2000
Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol (2011) 1.52
Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol (2008) 1.46
Drug induced interstitial lung disease. Open Respir Med J (2012) 1.12
Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist. Crit Care (2007) 1.10
Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens (2011) 1.06
The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis. Rheumatology (Oxford) (2012) 1.04
Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol (2015) 1.01
Microscopic polyangiitis. Rheum Dis Clin North Am (2010) 0.99
Diagnostic approach to patients with suspected vasculitis. Postgrad Med J (2006) 0.98
Role of bioactivation in drug-induced hypersensitivity reactions. AAPS J (2006) 0.96
Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases. Medicine (Baltimore) (2014) 0.94
Autoantibodies in vasculitis. Arthritis Res Ther (2003) 0.92
Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule. Clin Exp Immunol (2004) 0.89
The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis. Clin Kidney J (2015) 0.88
Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients. Autoimmune Dis (2011) 0.88
Clinical and laboratory characteristics of drug-induced vasculitic syndromes. Arthritis Res Ther (2005) 0.87
Glomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodies. ISRN Nephrol (2013) 0.87
Two cases of hypertrophic pachymeningitis associated with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive pulmonary silicosis in tunnel workers. Clin Rheumatol (2003) 0.85
Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity. Clin Exp Immunol (2005) 0.82
A case of ANCA-associated systemic vasculitis induced by atorvastatin. Clin Rheumatol (2008) 0.82
Drug-induced bullous sweet syndrome with multiple autoimmune features. Autoimmune Dis (2010) 0.81
Cutaneous vasculitis in breast cancer treated with chemotherapy. Clin Immunol (2008) 0.81
Microscopic polyangiitis initiated with liver dysfunction, calf pain and fever of unknown origin. Rheumatol Int (2009) 0.80
Systemic sclerosis, pulmonary fibrosis and anti-MPO antibodies. Clin Rheumatol (2005) 0.79
Hydralazine induces myeloperoxidase and proteinase 3 anti-neutrophil cytoplasmic antibody vasculitis and leads to pulmonary renal syndrome. Case Rep Nephrol (2014) 0.76
Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis. Biomed Res Int (2015) 0.76
Pauci-immune crescentic glomerulonephritis associated with use of trimethoprim-sulfamethoxazole. CEN Case Rep (2016) 0.75
Pathogenesis of ANCA-associated vasculitis. Rheum Dis Clin North Am (2010) 0.75
Rheumatic diseases induced by drugs and environmental factors: the state-of-the-art - part two. Reumatologia (2016) 0.75
A Case of Concurrent MPO-/PR3-Negative ANCA-Associated Glomerulonephritis and Membranous Glomerulopathy. Case Rep Nephrol (2015) 0.75
Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report. J Med Case Rep (2013) 0.75
ANCA-positive pauci-immune glomerulonephritis and febuxostat treatment. Clin Kidney J (2012) 0.75
Rare adverse effect of a common drug: nitrofurantoin-induced ANCA-associated vasculitis. BMJ Case Rep (2015) 0.75
Hydralazine-induced pauci-immune glomerulonephritis: intriguing case series with misleading diagnoses. J Community Hosp Intern Med Perspect (2016) 0.75
Onset of Microscopic Polyangiitis in Binephrectomied Patient on Chronic Hemodialysis-Case Report. Front Immunol (2017) 0.75
An Elderly Man with Fatigue, Dyspnea, and Kidney Failure. Clin J Am Soc Nephrol (2017) 0.75
Diffuse alveolar haemorrhage secondary to propylthiouracil-induced vasculitis. BMJ Case Rep (2015) 0.75
A challenging twist in pulmonary renal syndrome. Case Rep Rheumatol (2014) 0.75
ANCA-associated vasculitis in systemic sclerosis report of 3 cases. Rheumatol Int (2012) 0.75
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18
Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med (1988) 6.36
Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med (2000) 5.37
Confounding by indication. Epidemiology (1996) 5.01
EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis (2008) 4.88
Concepts of interaction. Am J Epidemiol (1980) 4.80
Reporting the results of epidemiologic studies. Am J Public Health (1986) 4.14
Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med (2001) 3.92
Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum (1995) 3.89
Epidemiology and the internet. Epidemiology (1997) 3.48
Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med (1995) 3.29
Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group. N Engl J Med (1993) 3.27
A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum (2001) 3.15
Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology (1999) 2.69
Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65
Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science (1989) 2.48
Low power and striking results--a surprise but not a paradox. N Engl J Med (1995) 2.37
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2008) 2.25
The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum (1994) 2.06
Fenoterol and fatal asthma. Lancet (1990) 2.05
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis (2007) 2.01
The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med (1992) 1.98
Risk factors for postherpetic neuralgia. Arch Intern Med (1997) 1.79
Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology (1995) 1.76
A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol (1987) 1.75
The epidemic of endometrial cancer: a commentary. Am J Public Health (1980) 1.74
Vaginal spermicides and congenital disorders. JAMA (1981) 1.74
Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study. Circulation (1998) 1.74
The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ (1992) 1.72
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology (2001) 1.71
Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst (1997) 1.68
Verotoxin producing Escherichia coli O 157 infections associated with the consumption of yoghurt. Epidemiol Infect (1993) 1.65
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2000) 1.62
Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum (2000) 1.57
Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis. Arch Ophthalmol (1982) 1.56
Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non-steroidal anti-inflammatory drugs in Italy. Eur J Clin Pharmacol (1998) 1.55
Vasectomy and non-fatal myocardial infarction. Lancet (1981) 1.54
Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology (1992) 1.52
Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters. Pharmacoepidemiol Drug Saf (2001) 1.52
Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology (1976) 1.51
Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol (2001) 1.51
Projections of asbestos-related disease 1980-2009. J Occup Med (1983) 1.49
Comparing imperfect measures of exposure. Am J Epidemiol (1985) 1.48
Left and right ventricular myocardial morphometry in fetal, neonatal, and adult sheep. Am J Physiol (1989) 1.47
Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis. Arthritis Rheum (1999) 1.47
Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf (1996) 1.43
Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol Infect (1999) 1.43
Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med (1988) 1.43
Refractory ceramic fiber: toxicology, epidemiology, and risk analyses--a review. Inhal Toxicol (2000) 1.41
Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med (1997) 1.40
Continuous hemofiltration. N Engl J Med (1997) 1.40
Estrogen replacement therapy and urinary tract infections in postmenopausal women aged 45-89. Menopause (1998) 1.40
A case-control study of diet and cancer of the pancreas. Am J Epidemiol (1991) 1.40
Intensive hospital monitoring study of intravenous cimetidine. Arch Intern Med (1986) 1.38
Temporal and regional variation in hysterectomy rates in the United States, 1970--1975. Am J Epidemiol (1979) 1.37
Heterotopic ossification in the setting of neuromuscular blockade. Arthritis Rheum (1997) 1.37
Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol (1997) 1.35
Oral contraceptives and breast cancer. Am J Epidemiol (1980) 1.32
Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer (1992) 1.31
Methods for investigating localized clustering of disease. Historical aspects of leukaemia clusters. IARC Sci Publ (1996) 1.30
Models of varying parametric form in case-referent studies. Am J Epidemiol (1982) 1.30
Epidemiology of pancreas cancer (1988). Int J Pancreatol (1989) 1.27
Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. Chest (2000) 1.27
Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis (2007) 1.26
Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol (2006) 1.26
Anamorphic analysis: sampling and estimation for covariate effects when both exposure and disease are known. Biometrics (1982) 1.25
Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum (1997) 1.25
[Pancreatic cancer and ABO blood types: a study of cases and controls]. Med Clin (Barc) (1991) 1.24
Cancer of the corpus uteri: increasing incidence in the United States, 1970--1975. Am J Epidemiol (1979) 1.22
Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant (2005) 1.22
Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARC. Int J Cancer (1996) 1.21
Nutritional factors and pancreatic cancer: a case-control study from south-west Poland. Int J Cancer (1991) 1.21
Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system. Clin Pharmacol Ther (2012) 1.20
Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol (2001) 1.19
Multilevel modelling of the incidence of visceral leishmaniasis in Teresina, Brazil. Epidemiol Infect (2006) 1.19
Outbreak of Escherichia coli O157 in a nursery: lessons for prevention. Arch Dis Child (1999) 1.18
Hepatitis B immunization in UK renal units: failure to put policy into practice. Nephrol Dial Transplant (1994) 1.17
Atracurium--a post-marketing surveillance study: methods and U.S. experience. Br J Anaesth (1989) 1.17
Predictors of treatment failure in multiple drug-resistant falciparum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand. Am J Trop Med Hyg (1993) 1.16
Incidence of rheumatoid arthritis in central Massachusetts. Arthritis Rheum (1993) 1.14
A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma. Am J Ophthalmol (1986) 1.14
Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet (1987) 1.14
Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study. Cancer (1998) 1.13
Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol (1989) 1.12
Neonatal group B streptococcal disease. Lancet (2001) 1.12
Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int (1999) 1.11
Detection of two forms of GP330. Their role in Heymann nephritis. Am J Pathol (1993) 1.11
Significance tests represent consensus and standard practice. Am J Public Health (1986) 1.11
Statin use, hyperlipidaemia, and the risk of breast cancer. Br J Cancer (2002) 1.10
High prevalence of mefloquine-resistant falciparum malaria in eastern Thailand. Bull World Health Organ (1993) 1.10
Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. Am J Public Health (1987) 1.09
Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size. Epidemiol Infect (2009) 1.09
Preferential release of newly synthesized prolactin granules is the result of functional heterogeneity among mammotrophs. Endocrinology (1980) 1.07